Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	7 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ (1,104,242)	$ 5,369,223
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Formation costs paid by related party	10,000
Allocation of offering costs to warrant expense	741,209
Interest income earned		(746,120)
Change in fair value of warrant liabilities	273,958	(6,185,662)
Changes in current assets and liabilities:
Prepaid expenses	(699,834)	267,719
Due to sponsor		(10,000)
Accrued offering costs and expenses	58,681	416,069
Income taxes payable		88,687
Net cash used in operating activities	(720,228)	(800,084)
Cash flows from investing activities:
Investment of cash in Trust Account	(128,397,500)	(1,019,688)
Net cash used in investing activities	(128,397,500)	(1,019,688)
Cash flows from financing activities:
Proceeds from initial public offering, net of costs	124,096,500
Proceeds from private placement warrants	6,027,500
Proceeds from convertible promissory note - related party	253,378	500,000
Payment of promissory note to related party	(285,778)	1,265,000
Payment of deferred offering costs	(529,379)
Net cash provided by financing activities	129,562,221	1,765,000
Net change in cash	444,493	(54,772)
Cash – Beginning of the period		264,755
Cash – End of the period	444,493	209,983
Supplemental disclosure of non-cash financing activities:
Deferred offering costs paid by promissory note – related party	32,400
Deferred offering costs paid by Sponsor in exchange for issuance of Class B common stock	25,000
Deferred underwriting fee charged temporary equity	4,554,000
Initial warrant liability	15,085,335
Initial value of Class A common stock subject to possible redemption	$ 128,397,500